Britain covid-19 information Coronavirus Research Provident Manufacturing Updates Britain

Clinical trials applications for Coronavirus (COVID-19)

Reading now: 399
www.gov.uk

. The COVID-19 clinical trials unit mailbox will no longer be operational.We have separate guidance as below:The National Institute for Health Research (NIHR) are .

The MHRA, however, continues to support COVID-19 trials with ongoing regulatory and scientific input. We also continue to provide full regulatory support to key UK policy driving clinical trials.The MHRA has procedures for timely scientific advice, reviews and approvals and are ready to support manufacturers, researchers and other regulators.

Having considered the change in public health need accompanying the vaccine roll out and the changes to the NIHR UPH prioritisation scheme, as well as the evolving situation in the UK, all further COVID-19 applications and meeting requests will be considered according to usual timelines.Our are available and include the ability to arrange an informal 1 hour regulatory advice meeting to discuss any aspect of your clinical trial.

We are also able to extend the discussion to wider aspects such as future marketing authorisation.From 1 January 2022, all new Clinical Trials of Investigational Medicinal Products (CTIMPs) applications are prepared, submitted and reviewed via the combined review service.

Read more on gov.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA